Abcam (LON:ABC)‘s stock had its “buy” rating reissued by Peel Hunt in a report issued on Tuesday, ThisIsMoney.Co.Uk reports.

Separately, Berenberg Bank reduced their target price on shares of Abcam from GBX 1,510 ($19.73) to GBX 1,330 ($17.38) and set a “buy” rating on the stock in a report on Monday, March 25th.

Abcam stock opened at GBX 1,444 ($18.87) on Tuesday. Abcam has a twelve month low of GBX 1,006 ($13.15) and a twelve month high of GBX 1,588 ($20.75). The stock has a market capitalization of $2.96 billion and a PE ratio of 51.76.

Abcam Company Profile

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays.

Featured Story: What moving averages are used to define a golden cross?

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.